News Home

Should You Buy 111 Inc - ADR (YI) Stock After it Is Higher By 9.64% in a Week?

Wednesday, May 18, 2022 01:50 PM | InvestorsObserver Analysts
Should You Buy 111 Inc - ADR (YI) Stock After it Is Higher By 9.64% in a Week?

Overall market sentiment has been high on 111 Inc - ADR (YI) stock lately. YI receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bullish
111 Inc - ADR has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on YI!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With YI Stock Today?

111 Inc - ADR (YI) stock is higher by 2.25% while the S&P 500 is down -3.56% as of 1:45 PM on Wednesday, May 18. YI is higher by $0.04 from the previous closing price of $1.78 on volume of 485,340 shares. Over the past year the S&P 500 has fallen -5.28% while YI is down -83.23%. YI lost -$1.20 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for 111 Inc - ADR click here.

More About 111 Inc - ADR

111 Inc is engaged in online retail and wholesale pharmacy. It operates an integrated online and offline platform in the healthcare ecosystem in China. It is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in China. It manages operations into two segments: the B2C segment and the B2B segment. The B2B segment generates the vast majority of its revenue. Click Here to get the full Stock Report for 111 Inc - ADR stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App